FEB 18, 2020 6:33 PM PST

Are you at risk of endometrial cancer?

Are you concerned about endometrial cancer? New research published recently in the Journal of Medical Genetics has identified 24 genetic variants that predispose women to endometrial cancer. These findings could help women determine if they qualify as high-risk and improve screening and prevention methods.

The study, led by Professor Emma Crosbie from The University of Manchester, reviewed 149 scientific studies, making it the most comprehensive systematic review in the field of endometrial cancer. Researchers from The University of Manchester, University of Cambridge and Manchester University NHS Foundation Trust collaborated on the review. The study itself received funding from the NIHR Manchester Biomedical Research Centre.

According to the World Cancer Research Fund, endometrial cancer is the sixth most commonly occurring cancer in women and the 15th most commonly occurring cancer overall.

"Because many of the studies carried out to date have been of variable quality, we felt it was important to understand more fully genetic predispositions to endometrial cancer," said Professor Crosbie. "Our work, we hope, will facilitate personalized risk assessment so that prevention and screening could be targeted more efficiently."

In their analysis, the researchers determined that the genetic variants in HNF1B, KLF, EIF2AK, CYP19A1, SOX4 and MYC had particularly strong associations with endometrial cancer. Additionally, they concluded that nineteen other variants had genome-wide significance. Interestingly, they did not determine the MDM2 variant rs2279744 to be a risk factor.

The authors say that the risk is not so much the existence of one of these genetic variants, but the combined presence of multiple. As Science Daily explains, “when all 24 variants are combined in a so-called polygenic risk score, women who score within the top 1% have a risk of endometrial cancer 3.16 times higher than the mean risk.”

Crosbie also commented: "These genetic variants linked to endometrial cancer risk are involved in cell survival, estrogen metabolism and transcriptional control -- when the information stored in our DNA is converted into instructions for making proteins or other molecules.” The researchers recognize that their analysis is just the tip of the iceberg of understanding the full picture of endometrial cancer; nevertheless, they hope their findings will be helpful. “We think studies with larger cohorts are needed to identify more variants with genome-wide significance. But until data from larger and more diverse cohorts are available, these twenty-four SNPs are the most robust common genetic variants that affect endometrial cancer risk."

Sources: Journal of Medical Genetics, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
AUG 23, 2021
Cancer
A Safe and Effective Combination Therapy for Advanced Cancer
AUG 23, 2021
A Safe and Effective Combination Therapy for Advanced Cancer
Immunotherapies are emerging as a promising strategy for the treatment of late-stage cancers which currently have m ...
SEP 13, 2021
Cancer
Fat Loss can Predict Gastric Cancer Survival
SEP 13, 2021
Fat Loss can Predict Gastric Cancer Survival
Cancer cachexia is a metabolic disorder in cancer patients experiencing uncontrolled weight loss.  While cancer cac ...
SEP 23, 2021
Immunology
Enhanced Hamster Cells as Super Drug Factories
SEP 23, 2021
Enhanced Hamster Cells as Super Drug Factories
Antibodies are highly specialized proteins produced by the immune system that stick on to foreign invaders in the body w ...
NOV 14, 2021
Genetics & Genomics
Cancer Drug Target Could Actually Worsen Disease
NOV 14, 2021
Cancer Drug Target Could Actually Worsen Disease
Cancer drugs have been developed that target an enzyme, Shp2. But that enzyme has a more complex role than we knew.
DEC 02, 2021
Cancer
A New Method to Enhance Immunotherapy in Mouse Tumors
DEC 02, 2021
A New Method to Enhance Immunotherapy in Mouse Tumors
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, accounting for about 90% of pancre ...
Loading Comments...